Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Mexiletine hydrochloride

Copy Product Info
🥰Excellent
Catalog No. T1046Cas No. 5370-01-4
Alias Mexiletine HCl, KOE-1173 (hydrochloride), KO1173

Mexiletine hydrochloride (KOE-1173 hydrochloride) is a voltage-gated sodium channel blocker and a Class IB antiarrhythmic drug. Mexiletine hydrochloride exerts antiarrhythmic effects by inhibiting sodium current in myocardial cells, thereby reducing the rise rate of cardiac action potential (phase 0) and reducing the automaticity of Purkinje fibers.

Mexiletine hydrochloride

Mexiletine hydrochloride

Copy Product Info
🥰Excellent
Purity: 99.88%
Catalog No. T1046Alias Mexiletine HCl, KOE-1173 (hydrochloride), KO1173Cas No. 5370-01-4
Mexiletine hydrochloride (KOE-1173 hydrochloride) is a voltage-gated sodium channel blocker and a Class IB antiarrhythmic drug. Mexiletine hydrochloride exerts antiarrhythmic effects by inhibiting sodium current in myocardial cells, thereby reducing the rise rate of cardiac action potential (phase 0) and reducing the automaticity of Purkinje fibers.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
50 mg$35In StockIn Stock
100 mg$48In StockIn Stock
200 mg$59In StockIn Stock
500 mg$68In StockIn Stock
1 mL x 10 mM (in DMSO)$50In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.88%
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Mexiletine hydrochloride AI Summary
Mexiletine hydrochloride exhibits a diverse range of bioactivities. It demonstrates antiplasmodial activity against Plasmodium falciparum strains 7G8, GB4, and W2 with IC50 values of 12589.25 nM for 7G8 and GB4 and 6309.57 nM for W2. The compound also shows varying potency against other P. falciparum lines, including Dd2, ranging from 7079.5 nM to 12589.3 nM. Besides its antiplasmodial effects, Mexiletine hydrochloride is a potent modulator of Lamin A splicing with an IC50 of 11.2 nM and exhibits inhibitory activity against multiple targets such as GCN5L2, MPP8 Chromodomain, Histone Lysine Methyltransferase G9a, and Mammalian Selenoprotein Thioredoxin Reductase 1 with potencies ranging from 891.3 nM to 89125.1 nM. Additionally, it shows activity against Marburg Virus and Ebola Virus with AC50 values between 281.8 nM and 22.39 μM. In the context of sodium ion channels, Mexiletine hydrochloride inhibits NaV1.7, NaV1.1, and NaV1.5 in human and mouse models and provides analgesic effects in mice with an ED50 of 21.0 mg/kg, though it also reduces locomotor activity in mice with an ID50 of 45.0 mg/kg, yielding a therapeutic index of 2.1. The compound demonstrates limited efficacy against SARS-CoV-2 in Vero E6 cells with a low inhibition index of 0.1347 and exhibits moderate antifungal activity against Candida albicans (3.72%) but weak activity against Cryptococcus neoformans (-0.12%). Its antibacterial activity varies, showing inhibition percentages of 3.59% against E. coli, 13.5% against K. pneumoniae, 15.77% against P. aeruginosa, 22.29% against A. baumannii, and 13.57% against MRSA. In cardiovascular models, Mexiletine hydrochloride increases the arrhythmic threshold in guinea pig atria while exerting negative inotropic and chronotropic effects and inhibiting calcium-induced contractions in guinea pig aortic strips and smooth muscle. However, it also presents toxicity by impairing motor coordination in mice, with effects depending on the dosage and timing..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
Mexiletine hydrochloride (KOE-1173 hydrochloride) is a voltage-gated sodium channel blocker and a Class IB antiarrhythmic drug. Mexiletine hydrochloride exerts antiarrhythmic effects by inhibiting sodium current in myocardial cells, thereby reducing the rise rate of cardiac action potential (phase 0) and reducing the automaticity of Purkinje fibers.
In vitro
Mexiletine shortened the cardiac Purkinje fiber effective response period (ERP) less than the action potential duration (APD), resulting in higher ERP/APD ratios.Mexiletine had no significant effect on atrioventricular conduction velocity, resting membrane potential, sinus node autoregulation, systolic arterial pressure, left ventricular function, or QRS or QT intervals. Mexiletine inhibits the inward flow of sodium ions through inhibition of sodium channels (requiring pulse initiation and conduction), which in turn reduces the rate of action potential elevation.
In vivo
Mexiletine shortened the cardiac Purkinje fiber effective response period (ERP) less than the action potential duration (APD), resulting in higher ERP/APD ratios.Mexiletine had no significant effect on atrioventricular conduction velocity, resting membrane potential, sinus node autoregulation, systolic arterial pressure, left ventricular function, or QRS or QT intervals. Mexiletine inhibits the inward flow of sodium ions through inhibition of sodium channels (requiring pulse initiation and conduction), which in turn reduces the rate of action potential elevation.
SynonymsMexiletine HCl, KOE-1173 (hydrochloride), KO1173
Chemical Properties
Molecular Weight215.72
FormulaC11H18ClNO
Cas No.5370-01-4
SmilesCl.CC(N)COc1c(C)cccc1C
Relative Density.1.12 g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 50 mg/mL (231.78 mM), Sonication is recommended.
H2O: 21.6 mg/mL (100.13 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (9.27 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
H2O/DMSO
1mg5mg10mg50mg
1 mM4.6356 mL23.1782 mL46.3564 mL231.7819 mL
5 mM0.9271 mL4.6356 mL9.2713 mL46.3564 mL
10 mM0.4636 mL2.3178 mL4.6356 mL23.1782 mL
20 mM0.2318 mL1.1589 mL2.3178 mL11.5891 mL
50 mM0.0927 mL0.4636 mL0.9271 mL4.6356 mL
100 mM0.0464 mL0.2318 mL0.4636 mL2.3178 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Mexiletine hydrochloride | purchase Mexiletine hydrochloride | Mexiletine hydrochloride cost | order Mexiletine hydrochloride | Mexiletine hydrochloride chemical structure | Mexiletine hydrochloride in vivo | Mexiletine hydrochloride in vitro | Mexiletine hydrochloride formula | Mexiletine hydrochloride molecular weight